3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
5
Neoplasms
3
Stomach Neoplasms
2
Recurrence
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Sarcoma
1
Peritoneal Neoplasms
1
Pain, Postoperative
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Lymphedema
1
Locally Advanced Rectal Cancer
1
HER2 Positive Esophagogastric Cancer
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Cachexia
1
Advanced Esophageal Cancer
1
Interventions
Capecitabine
17
Oxaliplatin
12
Irinotecan
8
spartalizumab
6
Neoadjuvant Therapy
4
Immune Checkpoint Inhibitors
4
Fluorouracil
4
toripalimab
3
tislelizumab
3
Radiation
3
sintilimab
2
camrelizumab
2
Leucovorin
2
Celecoxib
2
nimotuzumab
1
irinotecan sucrosofate
1
XELOX
1
Thymalfasin
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Injections
1
HMPL-013
1
Folfox protocol
1
Diathermy
1
Combined Modality Therapy
1
Chemoradiotherapy
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Locally Advanced Rectal Cancer
×
Combined Modality Therapy
×
Clear all
NCT03034473
2023-12-28
TransValid-A
University Medical Center Goettingen
Phase NA
Unknown
200 enrolled